Fusen Pharmaceutical Company Limited announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 214.212 million compared to CNY 247.502 million a year ago. Operating income was CNY 46.848 million compared to CNY 33.680 million a year ago. Net income was CNY 43.919 million compared to CNY 34.934 million a year ago. Basic earnings per share from continuing operations was CNY 0.06 compared to CNY 0.04 a year ago.